In conclusion, we have demonstrated that EP1 antagonism or EP1 gene deletion limits BBB breakdown, attenuates hemorrhagic transformation, and significantly reduces MMP-9 and MMP-3 protein levels and activity following experimental ischemic stroke in rodents, which is likely due to reduced immune cell infiltration into the brain. Here, MMP9 is linked to ischemic stroke.